Antibiotic Coverage for Lower Extremity Cellulitis
For uncomplicated lower extremity cellulitis without systemic signs, treat with an antibiotic active against streptococci (such as cephalexin or dicloxacillin); however, if there is penetrating trauma, purulent drainage, MRSA colonization, injection drug use, or systemic signs of infection (SIRS), use vancomycin or another agent covering both MRSA and streptococci. 1
Treatment Algorithm Based on Clinical Presentation
Mild Cellulitis (No Systemic Signs)
- First-line: Anti-streptococcal agents
- Cephalexin (oral)
- Dicloxacillin (oral)
- Flucloxacillin (where available)
- Duration: 5 days minimum, extend if not improving 1
- Route: Oral therapy is as effective as parenteral for uncomplicated cases 2
The guideline is clear that typical cellulitis is predominantly streptococcal, and narrow-spectrum coverage is sufficient 1. This is supported by research showing no difference in outcomes between narrow and broad-spectrum antibiotics for uncomplicated cases 3.
Moderate Cellulitis (With Systemic Signs)
- Consider adding MSSA coverage to streptococcal coverage 1
- Many clinicians appropriately broaden coverage at this stage, though the guideline notes this as "weak" evidence
Severe Cellulitis (MRSA Risk Factors Present)
MRSA coverage is mandatory if ANY of these are present:
- Penetrating trauma
- Purulent drainage
- Known MRSA colonization
- Injection drug use
- SIRS (fever, tachycardia, tachypnea, abnormal WBC)
Recommended agents:
In MRSA-prevalent areas, trimethoprim-sulfamethoxazole demonstrated 91% success vs 74% for cephalexin 4. This is particularly relevant as MRSA comprised 62% of positive cultures in one study 4.
Severely Compromised Patients
- Broad-spectrum coverage: Vancomycin PLUS piperacillin-tazobactam or a carbapenem 1
- This covers MRSA, streptococci, and gram-negative organisms
Critical Pitfalls to Avoid
Do NOT routinely use broad-spectrum antibiotics for uncomplicated cellulitis - this is common but unjustified 3. The research shows 100% of patients received broad-spectrum antibiotics pre-guideline implementation, but outcomes were identical to narrow-spectrum therapy 3.
Do NOT add benzylpenicillin to flucloxacillin - combination therapy showed no benefit over flucloxacillin alone for lower limb cellulitis 5.
Do NOT skip examination of toe web spaces - treating interdigital tinea/maceration reduces recurrence risk 1. Toe web intertrigo was present in 63.7% of cases and significantly associated with recurrence 6.
Essential Adjunctive Measures
Beyond antibiotics, these interventions are equally important 1:
- Elevate the affected limb
- Treat underlying edema (compression if venous insufficiency)
- Address toe web disease (antifungals for tinea)
- Manage predisposing conditions (diabetes control, obesity)
Duration and Monitoring
- Standard duration: 5 days 1
- Extend if: No improvement by day 5
- Hospitalize if: SIRS present, hemodynamic instability, concern for necrotizing infection, or severe immunocompromise 1
The evidence strongly supports that oral antibiotics work as well as IV for uncomplicated cases, with mean time to cessation of progression being 1.29 days for oral vs 1.78 days for IV 2.